Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Medical Innovation

New Jersey Innovation Institute Introduces Two Groundbreaking Biopharmaceutical Centers

Newark, NJ, June 24, 2017 — Companies in every sector are realizing that manufacturing matters.  For the biopharmaceutical industry, innovation is not about reducing unit part costs; instead, process technology is a strategic tool to reduce time to market, ensure consistent product quality and streamline regulatory approval.

As rapidly as science is advancing drug discovery, so too, must production technology keep pace.  But where will such innovation happen?

The New Jersey Innovation Institute (NJII) is answering this question. Continue reading

National Institute on Aging Report: Promising But Inconclusive Evidence on Interventions to Prevent Cognitive Decline, Dementia

Bethesda, MD, June 23, 2017 — The public is enormously concerned about dementia and cognitive impairment, and a wide range of programs and products, such as diets, exercise regimens, games, and supplements, purport to keep these conditions at bay.

It is difficult for individuals, health care providers and policy makers to ascertain what has been demonstrated to prevent or reduce risk.

To help sort through the data and to understand the quality and weight of current evidence for possible interventions, the National Institute on Aging (NIA) at the National Institutes of Health (NIH), commissioned experts for an extensive scientific review and to provide recommendations for public health messaging and future research priorities. Continue reading

Opinion: Labor Leader Greg Lalevee on ‘Workers Win When Jersey Drug Companies Innovate’

Greg Lalevee

Springfield, NJ, June 21, 2017The Record/NorthJersey.com on June 15 published the following opinion piece by Greg Lalevee, Business Manager, the International Union of Operating Engineers Local 825:

New Jersey’s nickname, “Medicine Chest of the World,” is backed up by the numbers.

Our state is home to more than 3,000 life sciences establishments.  Thirteen of the world’s top 20 biopharmaceutical companies have made the Garden State their U.S. headquarters.

These firms are innovating and saving lives every day — and they couldn’t do it without help from supportive government policies and New Jersey’s well-trained and talented union workforce. Continue reading

Opinion: Assemblyman Gary Schaer on ‘A Blueprint for Tomorrow’

Asm. Gary Schaer

Trenton, NJ, June 20, 2017Assemblyman Gary S. Schaer (D-Passaic), Chair of the Assembly Budget Committee, last month shared the following with Innovation New Jersey readers:

Each time we tackle the state budget, we are reminded that it is a living, breathing document that, at its core, should fundamentally reflect our priorities.  As we enter final deliberations in crafting this year’s state budget, that reminder is all the more potent.

One of the reasons New Jersey’s economy lagged far behind most of the nation after the Great Recession is because we failed to make the proper investments to capitalize on our strengths and leverage our assets to grow our economy.  We cannot expect to move forward and grow as a state without planting the proper seeds.  Continue reading

Trump Names Dr. Norman Sharpless to Serve as Director of National Cancer Institute

Dr. Norman “Ned” Sharpless

Washington, DC, June 19, 2017Science reports that President Donald Trump on June 9 announced his intention to appoint Norman “Ned” Sharpless, M.D., to be the next director of the National Cancer Institute (NCI) in Bethesda, Maryland.

Dr. Sharpless would succeed Harold Varmus as the head of NCI.

Sharpless, 50, is a physician and currently director of the Lineberger Comprehensive Cancer Center at the University of North Carolina in Chapel Hill.  He also holds an academic appointment at the university’s school of medicine. Continue reading

NJBIA’s Melanie Willoughby on ‘NJ’s Innovation Ecosystem Taking Shape’

Melanie Willoughby

Trenton, NJ, June 18, 2017In the June “Innovative State” issue of New Jersey Business, the monthly magazine of the New Jersey Business & Industry Association, Melanie Willoughby, NJBIA Chief Government Affairs Officer, writes:

In today’s business world, anyone with a car can be a taxi-cab company, anyone with a house can be a hotel, and we all can walk around with desktop computers in our pockets.

Few people predicted these developments, but those who shape their organizations to be innovative are in a stronger position to take advantage of whatever changes are in store in the future. Continue reading

Inspira Health Network Launches Innovation to Accelerate Development of Patient-Focused Products

Mullica Hill, NJ, June 16, 2017 — Anjalee Khemlani reports in NJBIZ that Inspira Health Network is joining the growing trend of health care providers investing in innovation.

The health system announced Wednesday the establishment of the Inspira Innovation Center.

The center will focus on accelerating development and implementation of patient-focused products and technologies, according to a company statement. Continue reading

NIAID Scientists Discover Rare Genetic Susceptibility to Common Cold

Washington, DC, June 16, 2017 — Scientists have identified a rare genetic mutation that results in a markedly increased susceptibility to infection by human rhinoviruses (HRVs) — the main causes of the common cold.

Colds contribute to more than 18 billion upper respiratory infections worldwide each year, according to the Global Burden of Disease Study.

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, identified the mutation in a young child with a history of severe HRV infections. Continue reading

Rutgers Researchers Invent Lab-on-a-Chip Technology That Could Lead to Wearable Biosensors

Dr. Mehdi Javanmard

New Brunswick, NJ, June 15, 2017 — Imagine wearing a device that continuously analyzes your sweat or blood for different types of biomarkers, such as proteins that show you may have breast cancer or lung cancer.

Rutgers engineers have invented biosensor technology — known as a lab on a chip — that could be used in hand-held or wearable devices to monitor your health and exposure to dangerous bacteria, viruses and pollutants.

“This is really important in the context of personalized medicine or personalized health monitoring,” said Mehdi Javanmard, Ph.D., an assistant professor in the Department of Electrical and Computer Engineering at Rutgers University-New Brunswick. Continue reading

New Jersey Business Magazine’s June 2017 Issue Spotlights ‘The Innovative State’

Trenton, NJ, June 14, 2017 — The annual June 2017 “Innovative State” edition of New Jersey Business magazine, a publication of New Jersey Business & Industry Association (NJBIA), includes an array of articles spotlighting the many high-tech industries, academic institutions and organizations that make the state a true center for research and development.

A separate feature article examines employees benefits, and an entire special section is devoted to what colleges and universities offer the business community in the innovation sphere.

Please click here to view the entire June edition.\

This free digital issue of the NJBIZ’s monthly magazine is brought to you by Raich Ende Malter & Co. LLP.